Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −12,048−100.0% | Sold out | Holders |
| Q4 2022 | 12,048 | $16.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 12,048 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 12,048 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 12,048 | $13.0K | <0.1% | +12,048 | New | Holders |